Advertisement

Strand-Break Repair and Radiation Resistance

  • George Shenouda
Chapter
Part of the Cancer Drug Discovery and Development book series (CDD&D)

Abstract

Radiotherapy is at the dawn of a new era, in which molecular radiation biology is coming into use for clinical decision-making. During the last decade of the 20th century, new research and technical developments were achieved. A new three-dimensional (3D) treatment optimization technology became available. In addition new biological principles are better understood for application in the area of clinical radiation oncology.

Keywords

Radiation Resistance Radiation Sensitivity Ataxia Telangiectasia Buthionine Sulfoximine Supraglottic Larynx 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Morgenbesser SD, Williams BO, Jacks T, et al. P53-depdendent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;871:72–74.CrossRefGoogle Scholar
  2. 2.
    Lane D. P53, guardian of the genome. Nature 1992;858:15–16.CrossRefGoogle Scholar
  3. 3.
    Oleinick NL, Chiu S, Friedman LR, et al. DNA—protein crosslinks: new insights into their formation and repair in irradiated mammalian cells. In: Simic MG, Grossman L, Upton AC, eds. Mechanism of DNA Damage and Repair Repair, Plenum, New York, 1986:181–192.CrossRefGoogle Scholar
  4. 4.
    Radford IR. Effect of radiomodifying agents on the ratios of X-ray-induced lesions in cellular DNA: use in lethal lesions determination. Int J Radiat Biol 1986;49:621–637.CrossRefGoogle Scholar
  5. 5.
    Fornace AJ, Little JB. DNA crosslinking induced by X-rays and chemical agents. Biochim Biophys Acta 1977;477:343–355.PubMedCrossRefGoogle Scholar
  6. 6.
    Cutler RG. Crosslinkage hypothesis of aging: DNA adducts in chromatin as a primary aging process. In: Smith KD, ed. Aging, Carcinogenesis, and Radiation Biology. Plenum, New York, 1976;443–492.Google Scholar
  7. 7.
    Cerutti PA. Base damage induced by ionizing radiation. In: Wang SY, ed. Photochemistry and Photobiology of Nucleic Acids. Wang Academic, New York, 1976;vol II:375–401.Google Scholar
  8. 8.
    Cerutti PA. Effects of ionizing radiation on mammalian cells. Naturwissenschaften 1974;61:51–59.PubMedCrossRefGoogle Scholar
  9. 9.
    Patil MS, Locher SE, Hariharan PV. Radiation induced thymine base damage and its excision repair in active and inactive chromatin of HeLa cells. Int J Radiat Biol 1985;48:691–700.CrossRefGoogle Scholar
  10. 10.
    Brent TP. Purification and characterization of human endonucleases specific for damaged DNA. Analysis of lesions induced by UV or X-radiation. Biochim Biophys Acta 1976;454: 172–183.PubMedCrossRefGoogle Scholar
  11. 11.
    Grosovsky AJ, De Boer JG, Drobetsky EA, et al. DNA sequence analysis of ionizing radiation induced mutation in mammalian cells. 8(th) Int Congr Radiat Res 1987; abstract 217.Google Scholar
  12. 12.
    Ahnström G Edvarsson KA. Radiation-induced single-strand breaks in DNA determined by rate of alkaline strand separation and hydroxylapatite chromatography: an alternative to velocity sedimentation. Int J Radiat Biol 1974;26:493–497.CrossRefGoogle Scholar
  13. 13.
    Coquerelle T, Bopp A, Kessler B, et al. Strand breaks and 5′-end groups in DNA of irradiated thymocytes. Int J Radiat Biol 1973;24:397–404.CrossRefGoogle Scholar
  14. 14.
    Kohn KW, Erickson, LC, Ewing RAG, et al. Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry 1976 15:4629–4637.PubMedCrossRefGoogle Scholar
  15. 15.
    Roots R, Yang, TC, Craise I, et al. Impaired repair capacity of DNA breaks induced in mammalian cellular DNA by accelerated heavy inns Raddiat. Res 1979;78; 38_49CrossRefGoogle Scholar
  16. 16.
    Sakai K, Okada S. Radiation-induced DNA damage and cellular lethality in cultured mammalian cells. Radiat Res 1984;98:479–490.PubMedCrossRefGoogle Scholar
  17. 17.
    Woods WG, Lopez, M, Kalvonjian M. Normal repair of gamma-radiation induced single- and double-strand DNA breaks in retinoblastoma fibroblasts. Biochim Biophys Acta 1982;698:40–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Lennartz M, Coquerelle T, Bopp A, et al. Oxygen effect on strand breaks and specific endgroups in DNA of irradiated thymocytes. Int J Radiat Biol 1975;27: 577–587.CrossRefGoogle Scholar
  19. 19.
    Palcic B, Skarsgard LD. The effects of oxygen on DNA single-strand breaks produced by ionizing radiation in mammalian cells. Int J Radiat Biol 1972;21:417–433.CrossRefGoogle Scholar
  20. 20.
    Koch CJ, Painter RB. The effects of extreme hypoxia on the repair DNA single-strand breaks in mammalian cells. Radiat Res 1975;64:256–269.PubMedCrossRefGoogle Scholar
  21. 21.
    Van der Schans GP, Centen HB, Lohman PHM. The induction of gamma endonucleasesusceptible sites by gamma rays in CHO cells and their cellular repair are not affect by the presence of thiol compounds during irradiation. Mutat Res 1979;59:119–122.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiu S, Oleinick NL, Friedman LR, et al. Hypersensitivity of DNA in transcriptionally active chromatin to ionizing radiation. Biochim Biophys Acta 1982;699:15–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Hariharan PV, Eleczko S, Smith BP, et al. Normal rejoining of DNA strand breaks in ataxia telangiectasia fibroblast lines after low X-ray exposure. Radiat Res 198186:589–597.PubMedCrossRefGoogle Scholar
  24. 24.
    Paterson MC, Smith BP, Lohman PHM, et al. Defective excision repair of gamma-ray damaged DNA in human (ataxia telangiectasia) fibroblasts. Nature 1976;260:444–446.PubMedCrossRefGoogle Scholar
  25. 25.
    Edgren M, Revesz L, Larsson A. Induction and repair of single-strand DNA breaks after X-irradiation of human fibroblasts deficient in glutathione. hit J Radiat Biol 1981;40:355–363.CrossRefGoogle Scholar
  26. 26.
    Revesz L, Edgren M. Glutathione dependent yield and repair of single-strand breaks in irradiated cells. Br J Cancer Res 1984;49(Suppl VI):55–60.Google Scholar
  27. 27.
    Blocher D. DNA double-strand breaks in Ehrlich ascites tumour cells at low doses of X-rays. Determination of induced breaks by centrifugation at reduced speed. Int J Radiat Biol 1982;42:317–328.CrossRefGoogle Scholar
  28. 28.
    Corry PM, Cole A. Radiation-induced double-strand scissions of the DNA of mammalian metaphase cells. Radiat Res 1968;36:528–543.PubMedCrossRefGoogle Scholar
  29. 29.
    Lehman AR, Stevens S. The production and repair of double-strand breaks in cells from normal humans and from patients with Ataxia telangiectasia. Biochim Biophys Acta 1977474:49–60.PubMedCrossRefGoogle Scholar
  30. 30.
    Elkind MM. DNA repair and cell repair, are they related? Int J Radiat Oncol Biol Phys 1979;5:1089–1094.PubMedCrossRefGoogle Scholar
  31. 31.
    Fankenberg-Schwager M, Frankenberg D, et al. Repair of DNA double-strand breaks in irradiated yeast cells under nongrowth conditions. Radiat Res 1980;82:498–510.CrossRefGoogle Scholar
  32. 32.
    Van der Schans GP, Centen HB, Lohman PHM. DNA lesions induced by ionizing radiation. In: Natarajan AT, Obe G, Altmann H, eds. Progress in Mutation Research. Elsevier, Amsterdam, 1982;vol 4, 285–299.Google Scholar
  33. 33.
    Van der Schans GP, Paterson MC, Cross WG. DNA strand breaks and rejoining in cultured human fibroblasts exposed to fast neutron or gamma rays. Int J Radiat Biol 1983;44:75–85.CrossRefGoogle Scholar
  34. 34.
    Coquerelle T, Weibezahn KF. Rejoining of DNA double-strand breaks in human fibroblasts and its impairment in one ataxia telangiectasia and two Fanconi strains. J Supramol Struct Cell Biochem 1981;17:369–376.PubMedCrossRefGoogle Scholar
  35. 35.
    Resnick MA. The repair of double strand breaks in DNA: a model involving recombination. J Theor Biol 1976;59:97–106.PubMedCrossRefGoogle Scholar
  36. 36.
    Weibezahn KF, Coquerelle T. Radiation-induced DNA double-strand breaks are rejoined by ligation and recombination process. Nucleic Acids Res 1981;9:3139–3150.PubMedCrossRefGoogle Scholar
  37. 37.
    Radford IR. The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation. Int J Radiat Biol 1990;48:45–54.CrossRefGoogle Scholar
  38. 38.
    Schwartz JL, Rotmensch J, Giovanazzi SM, et al. Faster repair of DNA double-strand breaks in radioresistant human tumour cells. Intl J Radiat Oncol Biol Phys 1988;15:907–912.CrossRefGoogle Scholar
  39. 39.
    Kelland LR, Edwards SM, Steel G. Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity. Radiat Res 1988;116:526–538.PubMedCrossRefGoogle Scholar
  40. 40.
    Green A, Pager A, Stout PM, et al. Relationships between DNA damage and the survival of radiosensitive mutant Chinese hamster cell lines exposed to gamma-radiation. Part I: intrinsic radiosensitivity. Intl J Radiat Biol 1992;61:465–472.PubMedCrossRefGoogle Scholar
  41. 41.
    Alaoui-Jamali MA, Batist G, Lehnert S. Radiation-induced damage to DNA in drug and radiation-resistant sublines of a human breast cancer cell line. Radiat Res 1992;129:37–42.PubMedCrossRefGoogle Scholar
  42. 42.
    Chang EH, Pirollo KF, Zou ZQ, et al. Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. Science 1987;234:1036–1039.CrossRefGoogle Scholar
  43. 43.
    Kasid UN, Pfeifer A, Weichselbaum RR, et al. The ras oncogene is associated with a radiationresistant human laryngeal cancer. Science 1987;234:1039–1041.CrossRefGoogle Scholar
  44. 44.
    Fitz Gerald TJ, Daugherty C, Kase K, et al. Activated human N-ras oncogene enhances X-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Am J Cln Oncol 1985;8:517–522.CrossRefGoogle Scholar
  45. 45.
    Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988;239:645–647.PubMedCrossRefGoogle Scholar
  46. 46.
    Ling CC, Endlich B. Radioresistance induced by oncogenic transformation. Radiat Res 1989;120:267–279.PubMedCrossRefGoogle Scholar
  47. 47.
    McKenna WG, Weiss MC, Bakanauskas VJ, et al. The role of the H-ras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys 1990;18:849–859.PubMedCrossRefGoogle Scholar
  48. 48.
    Iliakis G, Metzger L, Muschel RJ, et al. Induction and repair of DNA double strand breaks in radiation-resistant cells obtained by transformation of primary rate embryo cells with oncogenes H-ras and v-myc. Cancer Res 1990;50:6575–6579.PubMedGoogle Scholar
  49. 49.
    Gordon DJ, Milner AW, Beaney RP, et al. The increase in radioresistance of V79 cells cultured as spheroids is correlated to changes in nuclear morphology. Radiat Res 1990;121:174–179.CrossRefGoogle Scholar
  50. 50.
    Kapiszewska M, Wright WD, Lange CS, et al. DNA supercoiling changes in nucleoids from irradiated L5178Y-S and -R cells. Radiat Res 1989;119:569–575.PubMedCrossRefGoogle Scholar
  51. 51.
    Burzio LO, Riquelme PT, Koide SS. ADP ribosylation of rate liver nucleosomal core histones. J Biol Chem 1979;254:3029–3037.PubMedGoogle Scholar
  52. 52.
    Riquelme PT, Burzio LO, Koide SS. Poly(ADP-ribose) synthetase activity in rat testis mitochondria. J Biol Chem 1979;254:3018–3028.PubMedGoogle Scholar
  53. 53.
    Endres M, Wang ZQ, Namura S, et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 1997; 17 1140:1143.Google Scholar
  54. 54.
    Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med 1997;3:1089.PubMedCrossRefGoogle Scholar
  55. 55.
    Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemiareperfusion. Trends Pharmacol Sci 1998:19:287.PubMedCrossRefGoogle Scholar
  56. 56.
    Paterson MC, Smith BP, Lohman PH, et al. Defective excision repair of gamma-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts. Nature 1976;260:444–447.PubMedCrossRefGoogle Scholar
  57. 57.
    Lavin MF, Davidson M. Repair of strand breaks in superhelical DNA of ataxia telangiectasia lymphoblastoid cells. Cell J Sci 1981;48:383–391.Google Scholar
  58. 58.
    Cole J, Arlett CF, Green MH, et al. Comparative human cellular radiosensitivity: II. The survival following gamma-irradiation of unstimulated (GO) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int J Radiat Biol 1988;54:929–943.PubMedCrossRefGoogle Scholar
  59. 59.
    Cornforth MN, Bedford JS. On the nature of a defect in cells from individuals with ataxiatelangiectasia. Science 1985;227:1589–1591.PubMedCrossRefGoogle Scholar
  60. 60.
    Marecki JC, McCord JM. The inhibition of poly (ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells. Arch Biochem Biophys 2002;402:227–234.PubMedCrossRefGoogle Scholar
  61. 61.
    Yu SW, Wang H, Poitras MF, et al. Mediation of poly(ADP-ribose) polymerase- l -dependent cell death by apoptosis-inducing factor. Science 2002;297(5579):259–263.PubMedCrossRefGoogle Scholar
  62. 62.
    Tsujimoto Y, Cossman E, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440–1443.PubMedCrossRefGoogle Scholar
  63. 63.
    McDonnell T, Troncosco P, Brisbay S, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940–6944.PubMedGoogle Scholar
  64. 64.
    Bhargava V, Kell D, Van de Rijn M, et al. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 1994;145:535–540.PubMedGoogle Scholar
  65. 65.
    Reed J, Meister L, Tanaka S, et al. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991;51:6529–6538.PubMedGoogle Scholar
  66. 66.
    Hockenberry D, Oltvai Z, Yin XM, et al. Bcl-2 functions in an antioxident pathway to prevent apoptosis. Cell 1993;75:241–251.CrossRefGoogle Scholar
  67. 67.
    Sandstrom P, Mannic M, Buttke T. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J Leukocyte Biol 1994;55:221–226.PubMedGoogle Scholar
  68. 68.
    Kane D, Saralin T, Auton S, et al. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 1993;262:1274–1276.PubMedCrossRefGoogle Scholar
  69. 69.
    Story M, Vochringer D, Malone C, et al. Radiation-induced apoptosis in sensitive and resistant cells isolated from a mouse lymphoma. Int J Radiat Biol 1994;66:659–669.PubMedGoogle Scholar
  70. 70.
    Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6:10–21.PubMedCrossRefGoogle Scholar
  71. 71.
    Saunders M, Dische S. Clinical results of hypoxic cell radiosensitization from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. BrJ Cancer 1996;27(Suppl): S271-S278.Google Scholar
  72. 72.
    Overgaard J. Sensitization of hypoxic tumor cells-clinical experience. Int J Radiat Biol 1989;56:801–811.PubMedCrossRefGoogle Scholar
  73. 73.
    Werner-Wasik M, Schmid CH, Bornstein L, et al. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phvs 1995;32:1309–1317.CrossRefGoogle Scholar
  74. 74.
    Fein DA, Le WR, Henlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077–2083.PubMedGoogle Scholar
  75. 75.
    Dubray B, Mosseri V, Brunin F, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201; 553–558PubMedGoogle Scholar
  76. 76.
    Dische S, Warburton MF, Saunders MI. Radiation myelitis and survival in the radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 1988;15:75–81.PubMedCrossRefGoogle Scholar
  77. 77.
    Sasai K, Ono K, Hiraoka M, et al. The effect of arterial oxygen content on the results of radiation therapy for epidermoid bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1989;16:1477–1481.PubMedCrossRefGoogle Scholar
  78. 78.
    Cole CJ, Pollack A, Zagars GK, et al. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys 1955;32:331–340.CrossRefGoogle Scholar
  79. 79.
    Greven KM, Solin LJ, Hanks GE. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 1990;65:908–912.PubMedCrossRefGoogle Scholar
  80. 80.
    Dunphy EP, Peterson IA, Cox RS, et al. The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate. Int JRadiat Oncol Biol Phys 1989;16:1173–1178.CrossRefGoogle Scholar
  81. 81.
    Siemann DW, Horsman MR, Chaplin DJ. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiother Oncol 1994;31: 117–122.PubMedCrossRefGoogle Scholar
  82. 82.
    Fenton BM, Lord EM, Paoni SF. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation. Radiat Res 2000;153:75–83.PubMedCrossRefGoogle Scholar
  83. 83.
    Kaanders JH, Pop LA, Manes HA, et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol 1998;48:115–122.PubMedCrossRefGoogle Scholar
  84. 84.
    Hoskin PJ, Saunders MI, Dische S. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer 1999;86:1322–1328.PubMedCrossRefGoogle Scholar
  85. 85.
    Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5–85. Radiother Oncol 1998;46:135–146.PubMedCrossRefGoogle Scholar
  86. 86.
    Von Pawel J, von Rosemeling R, Gatzemeier U, et al. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated nonsmall-cell lung tumors. J Clin Oncol 2000;18:1351–1359.Google Scholar
  87. 87.
    Rischin D, Peters L, Hicks R, et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol 2001;19:535–542.PubMedGoogle Scholar
  88. 88.
    Craighead PS, Pearcey R, Stuart G. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2000;48:791–795.PubMedCrossRefGoogle Scholar
  89. 89.
    Kovacs MS, Hocking DJ, Evans JW, et al. Cisplatin anti-tumor potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br J Cancer 1999;80: 1245–1251.PubMedCrossRefGoogle Scholar
  90. 90.
    Goldberg Z, Evans J, Birrell G, et al. An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin. hit J Radiat Oncol Phys 2001;49:175–182.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • George Shenouda

There are no affiliations available

Personalised recommendations